SFRP1 and central nervous system cancer: Frequent methylation (55 %) of SFRP2 was also observed, but its relationship to glioma aggressiveness was not as straightforward as in the case of SFRP1. The methylation of SFRP2 did not correlate with either tumor grade or survival time.